www.newsmax.com
FDA Moves to Restrict Compounding GLP-1 Ingredients
The Food and Drug Administration said Friday it intends to restrict access to GLP-1 drug ingredients used in nonapproved compounded weight-loss products and that Hims & Hers Health Inc. could face federal enforcement, a move the agency said is aimed at curbing mass-marketed ...
New Posts (Home)
ChatBox
Popular Posts 
Game Zone
Top PodCasts
